Hematological Malignancies

Responses rates of Zevalin monotherapy versus R-chemo in first line therapy of Follicular NHL ORR (%) CR (%) Reference R-CHOP 96 20 Hiddemann et al., 2005 R-CVP 81 41 Marcus et al., 2005 R-MCP 92 50 Herold et al., 2005 Zevalin 84 53 Scholz et al., 2012 Zevalin 96 70 Illidge et al 2014 Bexxar 95 75 Kaminski et al., 2010